ISSN 1016-5169 | E-ISSN 1308-4488
pdf
Familial hypertrophic cardiomyopathy: A case with a new mutation in the MYBPC3 gene [Turk Kardiyol Dern Ars]
Turk Kardiyol Dern Ars. 2017; 45(5): 450-453 | DOI: 10.5543/tkda.2016.56267

Familial hypertrophic cardiomyopathy: A case with a new mutation in the MYBPC3 gene

Olgu Hallioglu Kilinc1, Dilek Giray1, Atil Bisgin2, Sevcan Tug Bozdogan3, Derya Karpuz1
1Department of Pediatric Cardiology, Mersin University Faculty of Medicine, Mersin, Turkey
2Department of Medical Genetics, Çukurova University Faculty of Medicine, Adana, Turkey
3Department of Medical Genetics, Mersin University Faculty of Medicine, Mersin, Turkey

Familial hypertrophic cardiomyopathy is a genetically heterogeneous disease with variable clinical features that is inherited as autosomal dominant with variable penetrance. Recent developments in genetics of hereditary cardiomyopathy have not only enlightened many points about pathogenesis, but have also provided great benefit to diagnostic approaches of clinicians. Heterozygous mutation of c3691-3692insTTCA in MYBPC3 gene was identified in a pediatric patient with diagnosis of hypertrophic cardiomyopathy at clinic. Hypertrophy was observed in sister and father of the patient in echocardiography screening, and it was subsequently determined that they also had same mutation. This mutation has not previously been defined and reported previously in the literature as cause of hypertrophic cardiomyopathy.

Keywords: Echocardiography, hypertrophic cardiomyopathy, molecular genetics, MYBPC.

Corresponding Author: Dilek Giray, Türkiye
Manuscript Language: English
×
APA
NLM
AMA
MLA
Chicago
Copied!
CITE


Journal Metrics

Journal Citation Indicator: 0.18
CiteScore: 1.1
Source Normalized Impact
per Paper:
0.22
SCImago Journal Rank: 0.348

Quick Search

Copyright © 2024 Archives of the Turkish Society of Cardiology



Kare Publishing is a subsidiary of Kare Media.